Related Experiment Video
Updated: May 14, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Management and Medical Care for Individuals with Type 1 Diabetes Running a Marathon
Michał Kulecki1,2, Marcin Daroszewski3, Paulina Birula1
1Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Mickiewicza 2, 60-834 Poznań, Poland.
Managing type 1 diabetes mellitus (T1DM) during marathons requires careful planning. This study shows that individualized insulin adjustments, carbohydrate intake, and medical support ensure safe completion for T1DM athletes.
Area of Science:
- Endocrinology
- Sports Medicine
- Diabetology
Background:
- Limited data exist on managing type 1 diabetes mellitus (T1DM) in endurance events.
- Marathon running presents unique glycemic control challenges for individuals with T1DM.
Purpose of the Study:
- To assess glycemic control and participant safety during a marathon.
- To evaluate the effectiveness of management strategies for T1DM during endurance events.
Main Methods:
- Five male T1DM participants completed a marathon with pre-race insulin dose reduction and specific meal timing.
- Glycemic monitoring utilized self-monitoring blood glucose (SMBG), two continuous glucose monitoring (CGM) systems, and ketone level checks.
- A dedicated medical team provided carbohydrate and fluid supplementation based on a pre-approved protocol.
Main Results:
- All participants successfully completed the marathon.
- Mean SMBG was 125.6 mg/dL, while CGM readings ranged from 149.6 to 155.4 mg/dL.
- Two participants experienced hypoglycemia, one prolonged and undetected by CGM, highlighting potential monitoring gaps.
Conclusions:
- Safe marathon completion for T1DM individuals necessitates individualized insulin adjustments and carbohydrate supplementation.
- Dedicated medical support and a combination of CGM with SMBG are crucial for detecting and managing glycemic excursions.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

